About 53 results

ALLMedicine™ Acute Myelomonocytic Leukemia Center

Research & Reviews  20 results

Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report.
Medicine Ji J, Li Y et. al.

Apr 14th, 2021 - Pure erythroid leukemia is a rare subcategory of acute myeloid leukemia characterized by predominant immature erythroid population. Its occurrence subsequent to acute myelomonocytic leukemia has not been reported before. We reported this rare case...

Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal...
Anticancer Research; Thadi A, Lewis L et. al.

Sep 4th, 2020 - Anticancer peptide PNC-27 binds to HDM-2 protein on cancer cell membranes inducing the formation of cytotoxic transmembrane pores. Herein, we investigated HDM-2 membrane expression and the effect of PNC-27 treatment on human non-stem cell acute my...

LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.
Molecular Cancer Therapeutics; Anami Y, Deng M et. al.

Sep 4th, 2020 - Acute myeloid leukemia (AML) is the most common and aggressive blood cancer in adults. In particular, significant unmet medical needs exist for effective treatment strategies for acute myelomonocytic leukemia (M4) and acute monocytic leukemia (M5)...

Penile Ulcer due to Leukemia Cutis-A Rare Diagnosis Not to Be Missed.
The American Journal of Dermatopathology; Toh JJH, Chia HY et. al.

Jan 9th, 2020 - We present a rare case of leukemia cutis presenting with an ulcer on the ventral penis. A 60-year-old Chinese man was referred for a penile ulcer of 10 days. He was diagnosed with acute myelomonocytic leukemia 6 months earlier and had received 2 c...

Epidemiology of transmitted drug resistance mutations in an HIV-1 subtype C high-preval...
Journal of Global Antimicrobial Resistance; D Moro AL, Rigatto MH

Nov 20th, 2019 - Granulocytic sarcoma (GS), also known as chloroma, is a tumor comprising myeloblasts or monoblasts, potentially occurring as an extramedullary mass. Systemic chemotherapy should be used to induce complete remission. However, such patients with chl...

see more →

News  1 results

Outcomes worse with secondary and therapy-related AML compared with de novo AML
Jennifer Kelly Shepphird

Aug 24th, 2015 - Clinical outcomes were significantly worse among younger patients with secondary and therapy-related acute myeloid leukemia (sAML and tAML, respectively) compared with de novo disease, suggesting the presence of distinct AML subtypes, in a study p.

see more →